Gene therapy frees hemophilia patient from constant worry, needles — Harvard Gazette
11 Articles
11 Articles
Gene therapy frees hemophilia patient from constant worry, needles — Harvard Gazette
Health Stopping the bleeding Terence Blue has spent his life managing hemophilia. A new gene therapy offers relief from constant worry and daily needles — ‘I am actually healing faster than I ever have.’ Alvin Powell Harvard Staff Writer April 18, 2025 long read In early February, Terence Blue became the first patient in New England to receive a new gene therapy for hemophilia B, at Harvard-affiliat…
Importance of hemophilia patients’ treatment underlined
A representational image showing children during blood transfusion. — AFP/FilePESHAWAR: Speakers at a function on Thursday said hemophilia patients had reduced ability for blood clotting and if not treated in time, children suffering from this blood disorder may face permanent disability.A...
Lack of life-saving medicine poses threat to hemophilia patients - Kashmir Media Service
Srinagar: The shortage of essential, life-saving hemophilia drugs has been going on for a few months now, and is a regular issue every year. According to Kashmir Media Service, the patients suffering from hemophilia, many of them children as young as five-year old, gathered at the Press Colony in Srinagar to seek attention to their plight. Around 50 people gathered at Press Colony to protest the non-availability of Clotting Factors. The proteste…
Hemophilia control and treatment, one of Cuba’s priorities
HAVANA, Cuba, Apr 17 (ACN) The provision of medical care to hemophiliacs is in the hands of health professionals at the Institute of Hematology and Immunology of Havana who are committed to the fight against this inherited genetic disorder that impairs the body’s ability to make blood clots.
Inadequate treatment of hemophilia leads to permanent damage to joints and muscles
The Association of Hemophiliacs of Serbia marked today the World Day of Hemophilia with the aim of better informing the population, as well as raising awareness about this hereditary and rare disease that affects the natural blood clotting process.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage